Cardiff Oncology Inc (CRDF) — Cash Flow-to-Debt Ratio
Cardiff Oncology Inc (CRDF) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-5.97 Million could theoretically repay 0% of its total liabilities ($16.50 Million) in one year. Check Cardiff Oncology Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cardiff Oncology Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Cardiff Oncology Inc across 17 annual periods. Also explore Cardiff Oncology Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cardiff Oncology Inc (2009–2025)
Year-by-year debt coverage analysis for Cardiff Oncology Inc. For market capitalisation and broader financial context, see CRDF stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.30x | $-37.92 Million | $16.50 Million | ▲ +13.1% |
| 2024 | -2.65x | $-37.69 Million | $14.24 Million | ▼ -2.0% |
| 2023 | -2.60x | $-30.89 Million | $11.90 Million | ▲ +24.4% |
| 2022 | -3.43x | $-33.82 Million | $9.85 Million | ▼ -36.0% |
| 2021 | -2.52x | $-23.04 Million | $9.13 Million | ▼ -1.6% |
| 2020 | -2.48x | $-16.31 Million | $6.57 Million | ▼ -8.1% |
| 2019 | -2.30x | $-13.27 Million | $5.78 Million | ▲ +28.8% |
| 2018 | -3.23x | $-13.20 Million | $4.09 Million | ▲ +19.8% |
| 2017 | -4.03x | $-23.28 Million | $5.78 Million | ▼ -213.8% |
| 2016 | -1.28x | $-31.04 Million | $24.18 Million | ▼ -32.0% |
| 2015 | -0.97x | $-22.12 Million | $22.75 Million | ▼ -57.0% |
| 2014 | -0.62x | $-12.73 Million | $20.55 Million | ▲ +42.7% |
| 2013 | -1.08x | $-7.32 Million | $6.76 Million | ▼ -108.2% |
| 2012 | -0.52x | $-4.93 Million | $9.50 Million | ▼ -41.9% |
| 2011 | -0.37x | $-1.93 Million | $5.27 Million | ▲ +3.4% |
| 2010 | -0.38x | $-2.09 Million | $5.51 Million | ▼ -40.3% |
| 2009 | -0.27x | $-1.23 Million | $4.55 Million | — |